Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy




Panduru NM, Saraheimo M, Forsblom C, Thorn LM, Gordin D, Wadén J, Tolonen N, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group

2015

Diabetes Care

38

5

883

890

8

0149-5992

DOIhttps://doi.org/10.2337/dc14-2276




Last updated on 2024-26-11 at 19:58